FDA Approves Merck's KEYTRUDA® Combined With Trastuzumab and Chemotherapy as First-line Treatment in Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma Pharmaceutical Investing
Medtronic Announces CareGuidePro, a New Mobile App and Online Platform for Patients to Navigate Their Spinal Cord Stimulation Journey Medical Device Investing
FDA Accepts Amgen's Supplemental New Drug Application For Otezla® For Adults With Mild-To-Moderate Plaque Psoriasis Biotech Investing
MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics Psychedelics Investing
Braxia Scientific Introduces "Braxia Health" a Growing Network of Clinics Leading Novel Psychedelic Research and Treatments for Mental Disorders Psychedelics Investing
Bristol Myers Squibb to Take Part in the 2021 Bank of America Securities Health Care Conference Biotech Investing
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Champignon Brands Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Psychedelics Investing
BLU Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BELLUS Health Inc. Investors of Class Action and Lead Plaintiff Deadline: May 17, 2021 Biotech Investing
Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol Cannabis Investing News
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
